Novanta Inc. · NASDAQ:NOVT
Novanta — Baird 2025 Global Consumer, Technology & Services Conference
15 slides from Novanta's conference presentation, Jun 4, 2025
Slide 1: A Trusted Technology Partner
A Trusted Technology Partner JUNE 2025 Confidential 1 and Proprietary
Slide 2: Safe Harbor Statement
Safe Harbor Statement Certain statements in this presentation are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on current expectations and assumptions that are subject to risks and uncertainties. All statements contained in thi
Slide 3: We Deliver Innovations That Matter
We Deliver Innovations That Matter Serve as a trusted technology partner to Medical and Advanced Industrial OEMs delivering intelligent, mission critical solutions in the most demanding applications. Confidential 3 and Proprietary
Slide 4: A Trusted, Sole-Sourced Technology Partner to Leading Global OEMs
A Trusted, Sole-Sourced Technology Partner to Leading Global OEMs ~55% MEDICAL We enable productivity improvement in healthcare and industrial markets with secular growth Advanced Surgery Minimally Invasive Surgery Surgical Robotics Integrated OR Precision Medicine (% OF SALES) APPLICATION AREAS ~$9
Slide 5: Our Global Presence
Our Global Presence Taunton, UK Manchester, UK Berlin, Germany Ludwigsstadt, Germany Wackersdorf, Germany Seattle, WA Syracuse, NY Brno, Czech Republic Boston, MA Přelouč, Czech Republic Beijing, China Sacramento, CA Apex, NC Milan, Italy Tokyo, Japan Los Angeles, CA Barcelona, Spain Suzhou, China S
Slide 6: Our Strategy
Our Strategy Win in high Asset light growth segments business model RE & TALE LTU NT Sticky business model CU Allocate based on with winning OEMs Growth Returns cash-on-cash return R E V E N UE C A S H F LO W NO EM A V ST N TA SY GROWTH TAM expansion through Expand gross margins innovation and subsy
Slide 7: How We Operate
HOW WE OPERATE COHESIVE ENGAGED TEAMS EMPLOYEES Diverse, inclusive, Engage around a shared collaborative: vision and purpose committed to win M&A Talent Owner Mindset and Capital Novanta Allocation Business units with agility, speed, Leverage NOVANTA customer focus Scale WAY CULTURE Novanta Growth S
Slide 8: Novanta Businesses, aligned with end market growth themes
Novanta Businesses, aligned with end market growth themes PRECISION ROBOTICS AND ADVANCED PRECISION MANUFACTURING AUTOMATION SURGERY MEDICINE KEY APPLICATIONS Advanced material Metal-based additive Factory, warehouse & Medical & industrial Robotic surgery Minimally invasive Genomics, proteomics, In
Slide 9: Leading Technology Provider to Robotic Surgery Applications
Leading Technology Provider to Robotic Surgery Applications DOUBLE-DIGIT LONG-TERM MARKET GROWTH RATE Precision and proprietary technologies optimized for the most demanding applications <10% penetration of surgical robotics applications PRECISION MOTION AND FLUID / GAS MANAGEMENT SOLUTIONS FOR ROBO
Slide 10: Medical Growth Application: Surgical Smoke Removal
Medical Growth Application: Surgical Smoke Removal DOUBLE-DIGIT LONG-TERM MARKET GROWTH RATE APPLICATION CAPABILITY High growth medical market opportunity, estimated at 20% per year Integrated smoke evacuation increases safety, optimizes workflow and eliminates separate equipment INTEGRATED INSUFFLA
Slide 11: Intelligent Solutions for Precision Medicine Applications
Intelligent Solutions for Precision Medicine Applications HIGH-SINGLE-DIGIT LONG-TERM MARKET GROWTH RATE Enabling automation and cutting-edge capabilities for precision medicine equipment PRECISION MOTION RFID READER MACHINE VISION LIGHT ENGINE (sample movement (reagent & (sample scanning SUB-SYSTEM
Slide 12: Delivering Consistent Financial Results
Delivering Consistent Financial Results REVENUE ADJUSTED EBITDA FINANCIAL FRAMEWORK $949M $210M Mid to high single-digit organic growth +12% Double-digit reported CAGR +14% growth through CAGR acquisitions 100 bps per year of gross margin expansion $244M $42M Strong free cash flow generation 2012 20
Slide 13: Delivering Innovation Where It Matters Most
Delivering Innovation Where It Matters Most Advanced Surgery Precision Medicine Precision Manufacturing Robotics and Automation Confidential 13 and Proprietary
Slide 14: Use of Non-GAAP Measures
Use of Non-GAAP Measures The non-GAAP financial measures used in this presentation are Adjusted EBITDA and Adjusted Gross Profit Margin. The Company believes that these non-GAAP financial measures provide useful and supplementary information to investors regarding the operating performance of the Co
Slide 15: Non-GAAP Reconciliation
Non-GAAP Reconciliation THREE (in thousands of dollars) TWELVE MONTHS ENDED MONTHS ENDED Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Dec 31, Mar 28, 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 REVENUE Revenue (GAAP) $243,7
Novanta — Baird 2025 Global Consumer, Technology & Services Conference on 6ix